Sector
PharmaceuticalsOpen
₹2,082.7Prev. Close
₹2,082.7Turnover(Lac.)
₹17,685.38Day's High
₹2,102.8Day's Low
₹2,053.652 Week's High
₹2,402.952 Week's Low
₹1,795.2Book Value
₹607.84Face Value
₹2Mkt Cap (₹ Cr.)
94,869.5P/E
17.84EPS
116.81Divi. Yield
0.58No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 91.32 | 91.22 | 91 | 90.9 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 24,186.92 | 20,511.87 | 18,320.86 | 18,059.29 |
Net Worth | 24,278.24 | 20,603.09 | 18,411.86 | 18,150.19 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 11,771.67 | 11,055.93 | 11,025.66 | 10,080.58 |
yoy growth (%) | 6.47 | 0.27 | 9.37 | -20.16 |
Raw materials | -4,467.26 | -4,182.31 | -4,207.27 | -3,474.35 |
As % of sales | 37.94 | 37.82 | 38.15 | 34.46 |
Employee costs | -1,918.16 | -1,695.86 | -1,703.22 | -1,441.64 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | -161.53 | 1,629.7 | 1,811.46 | 1,793.93 |
Depreciation | -514.19 | -502.83 | -518.75 | -389.81 |
Tax paid | -27.17 | -371.08 | -324.7 | -449.27 |
Working capital | -135.75 | -894.67 | -203.16 | 1,003.92 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 6.47 | 0.27 | 9.37 | -20.16 |
Op profit growth | -89.76 | 7.15 | -8.54 | -53.5 |
EBIT growth | -105.27 | -10.39 | 2.01 | -56.58 |
Net profit growth | -114.99 | 72.99 | -45.89 | -57.19 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 22,192.11 | 19,656.34 | 16,269.98 | 16,192.79 | 14,926.99 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 22,192.11 | 19,656.34 | 16,269.98 | 16,192.79 | 14,926.99 |
Other Operating Income | 515.79 | 354.48 | 371.68 | 212.69 | 235.97 |
Other Income | 195.82 | 120.17 | 73.36 | 142.05 | 137.62 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,799.5 | 92.3 | 4,31,412.42 | 564.22 | 0.89 | 4,511.27 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,417.5 | 67.76 | 1,70,343.22 | 696 | 0.47 | 2,660 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,728 | 59.13 | 1,26,185.41 | 597 | 0.16 | 2,707 | 249.83 |
Cipla Ltd CIPLA | 1,516.6 | 23.57 | 1,22,510.62 | 1,210.53 | 1.05 | 4,495.16 | 411.56 |
Dr Reddys Laboratories Ltd DRREDDY | 1,275.2 | 19.73 | 1,06,522.7 | 387.3 | 0.63 | 4,602.9 | 377.56 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman (Non-Executive)
M D Gupta
Managing Director
Nilesh Deshbandhu Gupta.
Director & Chief Executive Officer
Vinita Gupta
Company Sec. & Compli. Officer
R V Satam
Independent Director
Jean-Luc Belingard
Director & Group CFO
Ramesh Swaminathan
Independent Director
Mark D McDade
Independent Director
K B S Anand
Independent Director
Jeffrey Kindler
Independent Director
Alfonso Zulueta
Independent Director
Punita Lal
Kalpataru Inspire 3rd Floor,
Off Western Exp HW Santacruz-E,
Maharashtra - 400055
Tel: 91-22-6640 2323
Website: https://www.lupin.com/
Email: investorservices@lupinpharma.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Lupin is an innovation led Transnational Pharmaceutical Company producing, developing and marketing a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ing...
Read More
Reports by Lupin Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.